Last reviewed · How we verify
NCT03972059
High Intensity Interval Circuit Training on Resting Metabolic Rate in Overweight Adults
NA trial testing Exercise training - Phase 1 in Overweight and Obesity in 20 participants. Completed in 20 August 2019.
20 July 2019
Quick facts
| Lead sponsor | University of Thessaly |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 8 April 2019 |
| Primary completion | 20 July 2019 |
| Estimated completion | 20 August 2019 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- Exercise training - Phase 1
- Exercise training - Phase 2
- Exercise training - Phase 3
Conditions studied
- Overweight and Obesity — all drugs for Overweight and Obesity →
Sponsor
University of Thessaly
Who can join
Adults 30 to 50, any sex, with Overweight and Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is the first study to examine changes in resting metabolic rate up to 72 hours following an exercise session, and how these changes may be affected by 12 weeks of high intensity interval circuit training (HIICT). Various training programs that have been implemented in previous studies have investigated changes in resting metabolic rate only for the first 2-8 hours following an exercise session. Briefly, the results of this study will provide insight into the following: 1. To what extent and for how long does HIICT increases the resting metabolic rate following an exercise session? 2. How can this exercise program enhance metabolism without any dietary or other exercise intervention? 3. What is the caloric deficit that will result from 3 months of HIICT and how to what extent this deficit will influence body weight reduction?
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03972059
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Overweight and Obesity
Currently open trials in the same condition.
- NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07230496 — A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healt · Phase 1 · recruiting
- NCT07313761 — A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered · Phase 1 · active not recruiting
- NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting
Other University of Thessaly trials
Trials by the same sponsor.
- NCT07376187 — Digital Physiotherapy for Pediatric Chronic Suppurative Lung Diseases · NA · not yet recruiting
- NCT07496151 — The Effectiveness of Neurodevelopmental Treatment (Bobath) and Functional Physiotherapy in Children With Cerebral Palsy. · NA · not yet recruiting
- NCT07420309 — Colonoscopy TRaining With or Without Artificial INtelligence Among Endoscopy Residents · NA · recruiting
- NCT07341711 — Long-term Adaptations of Skeletal Muscle After Hybrid Training. · NA · not yet recruiting
- NCT07380009 — Acceptability and Adherence to Different Dosing Regimens of the Multistrain Probiotic Vivomixx® 460 Neo 9 in Adults Rece · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03972059 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Thessaly
- Last refreshed: 6 November 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03972059.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing